FarahKhanKhalilMD

Pathology • Tampa, FL

Pulmonary Pathology, Anatomic Pathology, Clinical Pathology

Professor, Cell Biology/ Pathology and Oncologic Sciences, USF-Morsani

Join to view full profile

Dr. Khalil is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khalil's full profile

Already have an account?

Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Phone+1 813-745-3001

Education & Training

Carnegie Mellon University Heinz CollegeMaster of Medical Management, Business, 2017 - 2019
Carnegie Melon University Heinz SchoolMaster of Medical Managment, 2017 - 2019
H. Lee Moffitt Cancer Center and Research InstituteFellowship, Oncological Surgical Pathology, 2006 - 2007
University of South Florida MorsaniResidency, Pathology-Anatomic and Clinical, 2001 - 2006
Khyber Medical CollegeClass of 1996

Certifications & Licensure

MD State Medical License 2018 - 2026
FL State Medical License 2006 - 2025
DE State Medical License 2006 - 2011
American Board of Pathology Pathology - Anatomic/Pathology - Clinical

Awards, Honors, & Recognition

Pathologist of the Year Florida Society of Histotechnology, 2018

Publications & Presentations

PubMed

Real-World Biomarker Test Ordering Practices in Non-Small Cell Lung Cancer: Interphysician Variation and Association With Clinical Outcomes.
Jason M Baron, Sarrah Widatalla, Matthew A Gubens, Farah Khalil
JCO Precision Oncology. 2024-08-01
1 citations
Deceptive learning in histopathology.
Sahar Shahamatdar, Daryoush Saeed-Vafa, Drew Linsley, Farah Khalil, Katherine Lovinger
Histopathology. 2024-07-01
5 citations
Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study.
Sanja Dacic, William D Travis, Jennifer M Giltnane, Filip Kos, John Abel
Journal of Thoracic Oncology. 2024-05-01

Journal Articles

Advances in EGFR as a predictive marker in Lung Adenocarcinoma.
Khalil F, Altiok S, Cancer Control